Last reviewed 2026-06-02 · How we verify

Normezaton (NORFENEFRINE)

Phase 2 active Small molecule ✓ Verified Jun 2026

Normezaton (generic name: NORFENEFRINE) is a norfenefrine drug. It is currently in Phase 2 development.

Normetazone works by interacting with the body's sympathetic nervous system, which regulates various physiological processes such as heart rate and blood pressure.

Normezaton is a small molecule with synonyms including norfenefrine, norphenylephrine, and WV-569 free base.

Likelihood of approval

13.3% vs 15.3% industry baseline

If approved by FDA: likely 2031–2034

Steps remaining: Phase 3 → NDA/BLA submission

Confidence: Medium

Why this estimate

Baseline phase 2 → approval rate +15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
Cardiovascular Phase 3 risk -2.0pp
Modern cardiovascular outcome trials are large + long; many fail to beat aggressive standard-of-care.

Predicted approval windows by jurisdiction (conditional on FDA approval)

Regulator	Country	Likely year	Lag vs FDA
FDA	US	2031–2034	—
EMA	EU	2032–2035	+0.7 yr
MHRA	GB	2032–2035	+0.7 yr
Health Canada	CA	2032–2036	+0.9 yr
TGA	AU	2032–2036	+1.2 yr
PMDA	JP	2032–2036	+1.5 yr
NMPA	CN	2033–2037	+2.3 yr
MFDS	KR	2032–2036	+1.4 yr
CDSCO	IN	2032–2037	+1.8 yr
ANVISA	BR	2033–2037	+2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic name	NORFENEFRINE
Drug class	norfenefrine
Modality	Small molecule
Therapeutic area	Cardiovascular
Phase	Phase 2

Mechanism of action

Imagine your body's 'fight or flight' response, which is controlled by the sympathetic nervous system. Normetazone may help modulate this response, but exactly how it does this is not yet fully understood. It's like a fine-tuner for your body's automatic responses.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Normezaton CI brief — competitive landscape report
Normezaton updates RSS · CI watch RSS

Frequently asked questions about Normezaton

What is Normezaton?

Normezaton (NORFENEFRINE) is a norfenefrine drug.

How does Normezaton work?

Normetazone works by interacting with the body's sympathetic nervous system, which regulates various physiological processes such as heart rate and blood pressure.

What is the generic name of Normezaton?

NORFENEFRINE is the generic (nonproprietary) name of Normezaton.

What drug class is Normezaton in?

Normezaton belongs to the norfenefrine class. See all norfenefrine drugs at /class/norfenefrine.

What development phase is Normezaton in?

Normezaton is in Phase 2.

Drug class: All norfenefrine drugs
Therapeutic area: All drugs in Cardiovascular

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing